Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents

European Journal of Medicinal Chemistry
2014.0

Abstract

In order to develop a lead antimycobacterium tuberculosis compound, a series of 52, novel pyrrole hydrazine derivatives have been synthesized and screened which target the essential enoyl-ACP reductase. The binding mode of the compounds at the active site of enoyl-ACP reductase was explored using surflex-docking method. The binding model suggests one or two hydrogen bonding interactions between pyrrole hydrazones and InhA enzyme. Highly active compound 5r (MIC 0.2 μg/mL) showed hydrogen bonding interactions with Tyr158 and NAD(+) in the same manner as those of ligands PT70 and triclosan. The CoMFA and CoMSIA models generated with database alignment were the best in terms of overall statistics. The predictive ability of the CoMFA and CoMSIA models was determined using a test set of 13 compounds, which gave predictive correlation coefficients (r(pred)(2)) of 0.896 and 0.930, respectively.

Knowledge Graph

Similar Paper

Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents
European Journal of Medicinal Chemistry 2014.0
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors
European Journal of Medicinal Chemistry 2017.0
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties
European Journal of Medicinal Chemistry 2016.0
Synthesis, antimycobacterial activity and docking study of 2-aroyl-[1]benzopyrano[4,3- c ]pyrazol-4(1 H )-one derivatives and related hydrazide-hydrazones
Bioorganic & Medicinal Chemistry Letters 2017.0
Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents
European Journal of Medicinal Chemistry 2011.0
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis
European Journal of Medicinal Chemistry 2014.0
Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation
Bioorganic & Medicinal Chemistry Letters 2017.0
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties
European Journal of Medicinal Chemistry 2011.0
Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: An in silico approach
European Journal of Medicinal Chemistry 2015.0
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors
European Journal of Medicinal Chemistry 2020.0